ArticleSpringerPlus2013
The addition of bevacizumab to standard chemotherapy in breast cancer: which patient benefits the most?
Vibeke Kruse et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleSpringerPlus2013
Vibeke Kruse et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.